BR9706369A - Processo para tratamento de unhas humanas. - Google Patents

Processo para tratamento de unhas humanas.

Info

Publication number
BR9706369A
BR9706369A BR9706369-0A BR9706369A BR9706369A BR 9706369 A BR9706369 A BR 9706369A BR 9706369 A BR9706369 A BR 9706369A BR 9706369 A BR9706369 A BR 9706369A
Authority
BR
Brazil
Prior art keywords
human nails
nails
treatment
improving
hands
Prior art date
Application number
BR9706369-0A
Other languages
English (en)
Inventor
Debra A Park
Original Assignee
Dial Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dial Corp filed Critical Dial Corp
Publication of BR9706369A publication Critical patent/BR9706369A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção para ''PROCESSO PARA TRATAMENTO DE UNHAS HUMANAS". Um processo para aperfeiçoamento da fisiologia de unhas humanas, e, mais particularmente, a um processo para aperfeiçoamento da flexibilidade de unhas é revelado. O processo involve lavagem das mãos com uma composição de limpeza, ou na forma liquida ou na forma sólida, contendo pantenol, e seguido pelo enxaguamento das mãos com água.
BR9706369-0A 1996-12-18 1997-12-17 Processo para tratamento de unhas humanas. BR9706369A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3311896P 1996-12-18 1996-12-18

Publications (1)

Publication Number Publication Date
BR9706369A true BR9706369A (pt) 1999-12-07

Family

ID=21868661

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9706369-0A BR9706369A (pt) 1996-12-18 1997-12-17 Processo para tratamento de unhas humanas.

Country Status (5)

Country Link
US (1) US6017517A (pt)
AR (1) AR010790A1 (pt)
BR (1) BR9706369A (pt)
GT (1) GT199700134A (pt)
WO (1) WO1998026761A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002231736A1 (en) 2000-12-22 2002-07-08 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Use of repulsive guidance molecule (rgm) and its modulators
US6800295B2 (en) * 2002-10-09 2004-10-05 The Dial Corporation Water soluble sheet composition
US20070198196A1 (en) * 2004-08-24 2007-08-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods relating to ameliorating an immune system
ES2542501T3 (es) * 2005-09-30 2015-08-06 Abbvie Deutschland Gmbh & Co Kg Dominios de unión de proteínas de la familia de proteínas de moléculas de orientación repulsiva (RGM) y fragmentos funcionales de las mismas, así como su uso
EP2033971A1 (de) * 2007-09-06 2009-03-11 Abbott GmbH & Co. KG Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
SG181563A1 (en) 2009-12-08 2012-07-30 Abbott Gmbh & Co Kg Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
EP2791175A2 (en) 2011-12-14 2014-10-22 Abbvie Deutschland GmbH & Co. KG Composition and method for the diagnosis and treatment of iron-related disorders
CA2855840C (en) 2011-12-14 2023-08-29 AbbVie Deutschland GmbH & Co. KG Composition and method for the diagnosis and treatment of iron-related disorders
RU2644337C2 (ru) 2012-01-27 2018-02-08 Эббви Дойчланд Гмбх Унд Ко. Кг Композиции и способы диагностики и лечения заболеваний, ассоциированных с дегенерацией нейритов
US9469686B2 (en) 2013-03-15 2016-10-18 Abbott Laboratories Anti-GP73 monoclonal antibodies and methods of obtaining the same
US10183988B2 (en) 2013-06-07 2019-01-22 Duke University Anti-Complement factor H antibodies
US20180106800A1 (en) 2016-10-03 2018-04-19 Abbott Laboratories Methods of assessing uch-l1 status in patient samples
CA3052513A1 (en) 2017-03-23 2018-09-27 Abbott Laboratories Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
EP3610268A1 (en) 2017-04-15 2020-02-19 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
JP7080899B2 (ja) 2017-04-28 2022-06-06 アボット・ラボラトリーズ 同じヒト対象に由来する少なくとも２つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
US10865238B1 (en) 2017-05-05 2020-12-15 Duke University Complement factor H antibodies
CA3078725A1 (en) 2017-05-25 2018-11-29 Abbott Laboratories Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
AU2018275236A1 (en) 2017-05-30 2019-10-31 Abbott Laboratories Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
US11169159B2 (en) 2017-07-03 2021-11-09 Abbott Laboratories Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
AU2018378084A1 (en) 2017-12-09 2020-05-14 Abbott Laboratories Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
BR112019028254A2 (pt) 2017-12-09 2020-07-14 Abbott Laboratories métodos para ajudar no diagnóstico e avaliação de um paciente que sofreu uma lesão ortopédica e que sofreu ou pode ter sofrido uma lesão na cabeça, tal como uma lesão cerebral traumática (lct) leve, usando a proteína ácida fibrilar glial (gfap) e/ou a hidrolase carbóxi-terminal da ubiquitina l1 (uch-l1)
EP4136459A1 (en) 2020-04-13 2023-02-22 Abbott Laboratories Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
WO2022031804A1 (en) 2020-08-04 2022-02-10 Abbott Laboratories Improved methods and kits for detecting sars-cov-2 protein in a sample
US11988671B2 (en) 2020-08-04 2024-05-21 Abbott Rapid Diagnostics International Unlimited Company Assays for detecting SARS-CoV-2
WO2023102384A1 (en) 2021-11-30 2023-06-08 Abbott Laboratories Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
US20220170948A1 (en) 2020-12-01 2022-06-02 Abbott Laboratories Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
WO2022147147A1 (en) 2020-12-30 2022-07-07 Abbott Laboratories Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
BR112023024169A2 (pt) 2021-05-18 2024-02-06 Abbott Lab Métodos para avaliar lesão cerebral em um indivíduo pediátrico
EP4356129A1 (en) 2021-06-14 2024-04-24 Abbott Laboratories Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
WO2023034777A1 (en) 2021-08-31 2023-03-09 Abbott Laboratories Methods and systems of diagnosing brain injury
CA3232176A1 (en) 2021-09-30 2023-04-06 Beth MCQUISTON Methods and systems of diagnosing brain injury
WO2023114978A1 (en) 2021-12-17 2023-06-22 Abbott Laboratories Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
US20230213536A1 (en) 2021-12-28 2023-07-06 Abbott Laboratories Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
WO2023150652A1 (en) 2022-02-04 2023-08-10 Abbott Laboratories Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
WO2024006876A1 (en) 2022-06-29 2024-01-04 Abbott Laboratories Magnetic point-of-care systems and assays for determining gfap in biological samples
WO2024059708A1 (en) 2022-09-15 2024-03-21 Abbott Laboratories Biomarkers and methods for differentiating between mild and supermild traumatic brain injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33845A (en) * 1861-12-03 Improvement in harvesting-machines
US3034965A (en) * 1958-06-12 1962-05-15 Rose P Drake Composition and method for treating nails
GB1514469A (en) * 1974-08-01 1978-06-14 Beecham Group Ltd Oral hygiene compositions
US4158053A (en) * 1977-08-05 1979-06-12 Eli Lilly And Company Aqueous emulsion polymer nail coating formulations
US4402935A (en) * 1981-04-16 1983-09-06 Del Laboratories, Inc. Moisturizing nail polish composition
US4416873A (en) * 1982-06-01 1983-11-22 Charles Of The Ritz Group Ltd. Combined allantoin-hydrolyzed animal protein skin preparation
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
US4970220A (en) * 1982-05-17 1990-11-13 S. C. Johnson & Son, Inc. Skin conditioning composition
US4534964A (en) * 1982-10-04 1985-08-13 Richardson-Vicks Inc. Hair conditioning shampoo
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4851434A (en) * 1983-05-27 1989-07-25 Deckner George E Novel non-irritating moisturizer, compositions containing same and method
US4482537A (en) * 1983-09-19 1984-11-13 Charles Of The Ritz Group Ltd. Skin conditioning composition
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
US4595586A (en) * 1985-08-30 1986-06-17 Eli Lilly And Company Moisturizing lotion
JPS62111909A (ja) * 1985-11-09 1987-05-22 Shiseido Co Ltd 美爪料
US4690818A (en) * 1986-02-03 1987-09-01 Charles Of The Ritz Group Ltd. Shampoo and bath and shower gel
NL8601767A (nl) 1986-07-07 1988-02-01 Schreuder Chem Adviesbureau Huidbruiningsmiddel.
US4832872A (en) * 1988-01-22 1989-05-23 Richardson-Vicks Inc. Hair conditioning shampoo
US4857321A (en) * 1988-08-26 1989-08-15 Thomas William C Skin ointment
US5069898A (en) * 1989-04-24 1991-12-03 Revlon, Inc. Hair enrichment composition and method of use
US5041285A (en) * 1990-01-29 1991-08-20 Larry D. Lundmark Method of treating the hair with an allanoyoin-panthenol product
US5102654A (en) * 1990-04-18 1992-04-07 Revlon, Inc. Nail enamel emulsion lacquer comprising a water phase and a lacquer phase
US5136093A (en) * 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
AU3136593A (en) * 1991-11-22 1993-06-15 Richardson-Vicks Inc. Combined personal cleansing and moisturizing compositions
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
AU705449B2 (en) * 1994-08-26 1999-05-20 Procter & Gamble Company, The Personal cleansing compositions
US5445823A (en) * 1994-10-20 1995-08-29 The Procter & Gamble Company Dermatological compositions and method of treatment of skin lesions therewith

Also Published As

Publication number Publication date
GT199700134A (es) 1999-06-05
US6017517A (en) 2000-01-25
WO1998026761A1 (en) 1998-06-25
AR010790A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
BR9706369A (pt) Processo para tratamento de unhas humanas.
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
FI932200A0 (fi) Foer hudrengoering avsedd mild toalettbit, som innehaoller foer huden milt/fuktgivande silikonhjaelpmedel
BR8904828A (pt) Processo para preparacao de emulsoes de limpeza para tratamento de beleza,respectivas emulsoes e espumas de banho,locoes de limpeza,oleos de banho e sabonetes liquidos
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
DE69618787D1 (de) Topische zusammensetzungen mit verbessertem hautgefühl
DK0792144T3 (da) Rengøringsvæv behandlet med vand-i-lipid emulsion
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
ID28949A (id) Artikel-artikel penyerap yang menjaga atau memperbaiki kesehatan kulit
BR9802120A (pt) Composição cosmética e/ou dermatológica composição dermatologica processo de tratamento cosmético utilização de uma composição processo de conservação de composições e utilização de um polímero poliaminado
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE69008342T2 (de) Orthese für die Behandlung von Schienbeinverdrehungen bei Kindern.
DE3888904T2 (de) Hautreinigungsstück mit niedrigem Feuchtegehalt.
BR8603961A (pt) Composicao detergente para tratamento de tecidos;composicao detergente encorpada,nao aquosa para lavagem de roupas pesadas e composicao liquida e processo para limpar tecidos sujos
BR8907770A (pt) Solucao para tratamento de metal,solucao aquosa e processo para tratar uma superficie de metal
BR9609602A (pt) Composição cosmética anidra utilização da composição e processo de tratamento cosmético
DE69617963D1 (de) Behandlung von titandioxidaufachlämmungen mittels scherkräften
BR9300651A (pt) Processo para determinar a presenca e/ou concentracao de um polimero para tratamento de agua em uma amostra aquosa,hibridoma e composicao
SE9100480L (sv) Rengoeringsprodukt
BR9200687A (pt) Composicao detergente adequada para lavagem de tecidos,composicao reforcadora e detergencia e processo para lavar tecidos
ZA957506B (en) L-carnite salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
DE59002772D1 (de) Verwendung von Dextransulfat, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Behandlung des humanen Protatakarzinoms.
BR8902113A (pt) Composicao detergente liquida,aquosa,isotropica,e processo para tratar tecidos
BR9602639A (pt) Agente de enxaguamento macio contendo água para o tratamento de téxteis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1849 DE 13/06/2006.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 3/00 (2006.01), A61K 8/42 (2006.0